These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15871189)

  • 1. [Changes of serum asymmetric dimethylarginine in essential hypertension before and after the treatment].
    Zhang WR; Chen BM; Xiong Y; Tao LJ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Feb; 30(1):57-9. PubMed ID: 15871189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of asymmetric dimethylarginine on platelet-aggregation and losartan intervention in spontaneous hypertensive rat models].
    Xia K; Li D; Zhao ZY; Yang TL
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 31(5):645-9, 654. PubMed ID: 17062922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Impact of adding folic acid, vitamin B(12) and probucol to standard antihypertensive medication on plasma homocysteine and asymmetric dimethylarginine levels of essential hypertension patients].
    Wu CJ; Wang L; Li X; Wang CX; Ma JP; Xia XS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Dec; 40(12):1003-8. PubMed ID: 23363713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of losartan and enalapril therapies on the levels of nitric oxide, malondialdehyde, and glutathione in patients with essential hypertension.
    Donmez G; Derici U; Erbas D; Arinsoy T; Onk A; Sindel S; Hasanoglu E
    Jpn J Physiol; 2002 Oct; 52(5):435-40. PubMed ID: 12533248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renin-angiotensin system is involved in the mechanism of increased serum asymmetric dimethylarginine in essential hypertension.
    Ito A; Egashira K; Narishige T; Muramatsu K; Takeshita A
    Jpn Circ J; 2001 Sep; 65(9):775-8. PubMed ID: 11548874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum nitric oxide and D-dimer before and after administering antihypertensive drugs in essential hypertension].
    Zhang WR; Sun M; Luo JK
    Hunan Yi Ke Da Xue Xue Bao; 2003 Aug; 28(4):382-4. PubMed ID: 14653123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nebivolol treatment reduces serum levels of asymmetric dimethylarginine and improves endothelial dysfunction in essential hypertensive patients.
    Pasini AF; Garbin U; Stranieri C; Boccioletti V; Mozzini C; Manfro S; Pasini A; Cominacini M; Cominacini L
    Am J Hypertens; 2008 Nov; 21(11):1251-7. PubMed ID: 18772860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension.
    Napoli C; Sica V; de Nigris F; Pignalosa O; Condorelli M; Ignarro LJ; Liguori A
    Am Heart J; 2004 Jul; 148(1):e5. PubMed ID: 15215814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma asymmetric dimethylarginine, symmetric dimethylarginine, l-arginine, and nitrite/nitrate concentrations in cats with chronic kidney disease and hypertension.
    Jepson RE; Syme HM; Vallance C; Elliott J
    J Vet Intern Med; 2008; 22(2):317-24. PubMed ID: 18371026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of asymmetric dimethylarginine involved in the cardioprotective effect of losartan in spontaneously hypertensive rats.
    Li D; Xia K; Li NS; Luo D; Wang S; Jiang DJ; Deng HW; Li YJ
    Can J Physiol Pharmacol; 2007 Aug; 85(8):783-9. PubMed ID: 17901888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression.
    Selley ML
    J Affect Disord; 2004 Jun; 80(2-3):249-56. PubMed ID: 15207938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationship between serum asymmetric dimethylarginine and blood pressure in patients with chronic renal failure].
    Zhang WR; Tao LJ; Chen BM
    Hunan Yi Ke Da Xue Xue Bao; 2002 Apr; 27(2):133-4. PubMed ID: 12575339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension.
    Perticone F; Sciacqua A; Maio R; Perticone M; Maas R; Boger RH; Tripepi G; Sesti G; Zoccali C
    J Am Coll Cardiol; 2005 Aug; 46(3):518-23. PubMed ID: 16053968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased circulating concentrations of asymmetric dimethylarginine (ADMA) in white coat hypertension.
    Curgunlu A; Uzun H; Bavunoğlu I; Karter Y; Genç H; Vehid S
    J Hum Hypertens; 2005 Aug; 19(8):629-33. PubMed ID: 15829997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between blood asymmetric dimethylarginine level and the complications of patients with cardiovascular diseases.
    Wang D; Lai LH; Yan P; Dong PS
    J Biol Regul Homeost Agents; 2017; 31(1):133-139. PubMed ID: 28337882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of nebivolol and metoprolol treatments on serum asymmetric dimethylarginine levels in hypertensive patients with type 2 diabetes mellitus.
    Oğuz A; Uzunlulu M; Yorulmaz E; Yalçin Y; Hekim N; Fici F
    Anadolu Kardiyol Derg; 2007 Dec; 7(4):383-7. PubMed ID: 18065333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Serum Levels of Asymmetric Dimethylarginine and Symmetric Dimethylarginine and Decreased Levels of Arginine in Sudanese Patients with Essential Hypertension.
    Gamil S; Erdmann J; Schwedhelm E; Bakheit KH; Abdalrahman IBB; Mohamed AO
    Kidney Blood Press Res; 2020; 45(5):727-736. PubMed ID: 32814314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of l-arginine transport in platelets by asymmetric dimethylarginine and N-monomethyl-l-arginine: effects of arterial hypertension.
    Brunini T; Moss M; Siqueira M; Meirelles L; Rozentul A; Mann G; Ellory J; Soares de Moura R; Mendes-Ribeiro A
    Clin Exp Pharmacol Physiol; 2004 Oct; 31(10):738-40. PubMed ID: 15554917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asymmetric dimethylarginine and hemodynamic regulation in middle-aged men.
    Päivä H; Laakso J; Kähönen M; Turjanmaa V; Kööbi T; Majahalme S; Lehtimäki T; Ruokonen I; Laaksonen R
    Metabolism; 2006 Jun; 55(6):771-7. PubMed ID: 16713437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in hyperthyroid patients.
    Hermenegildo C; Medina P; Peiró M; Segarra G; Vila JM; Ortega J; Lluch S
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5636-40. PubMed ID: 12466365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.